- Selected new reviews and commentaries, 1 September 2010
- Turmoil as NIH halts human embryonic stem cell research
- Current DTC genetic testing market smaller than expected
- Battle over human embryonic stem cell research in U.S.
- How DNA loops create different cells and alter gene expression
- Genetic transcriptional signature to predict active TB
- FDA moves to halt unproven stem cell treatments
- New study points the way to muscular dystrophy therapies
- HLA region associated with Parkinson's disease
Expanded newborn screening
A review of the evidence for including new forms of inherited metabolic disease
Genomic Medicine
Independent response to the House of Lords Science and Technology Committee report
Predicting the risk of coronary heart disease
with conventional, genetic and novel molecular biomarkers
